Jabez Biosciences, Inc.

CIK 2038185 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Jabez Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Jun 12, 20261-Z0001213900-26-068313
Apr 30, 20261-K0001213900-26-050100
Mar 26, 2026D0001213900-26-034473
Oct 28, 2025D/A0001213900-25-103046
Oct 21, 2025D0001213900-25-100745
Oct 21, 2025D0001213900-25-100637
Sep 30, 20251-SA0001213900-25-093470
May 6, 20251-K0001213900-25-039855
Jan 10, 2025SEC STAFF LETTER9999999997-25-000090
Dec 20, 2024QUALIF9999999994-24-000217
Dec 12, 20241-A/A0001213900-24-108457
Dec 3, 20241-A/A0001213900-24-104981
Nov 20, 20241-A/A0001213900-24-100289
Nov 14, 2024SEC STAFF LETTER9999999997-24-004341
Oct 29, 20241-A/A0001213900-24-091806
Sep 23, 20241-A0001213900-24-080792